Literature DB >> 7768399

Consensus conference statement: Escherichia coli O157:H7 infections--an emerging national health crisis, July 11-13, 1994.

.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7768399

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  11 in total

1.  Haemolytic uraemic syndrome and E coli O157.

Authors:  M Fitzpatrick
Journal:  BMJ       Date:  1999-03-13

Review 2.  Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.

Authors:  Miguel O'Ryan; Roberto Vidal; Felipe del Canto; Juan Carlos Salazar; David Montero
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Effects of azithromycin on shiga toxin production by Escherichia coli and subsequent host inflammatory response.

Authors:  Tatsuki Ohara; Seiichi Kojio; Ikue Taneike; Saori Nakagawa; Fumio Gondaira; Yukiko Tamura; Fumitake Gejyo; Hui-Min Zhang; Tatsuo Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

4.  Performance of the ImmunoCard STAT! E. coli O157:H7 test for detection of Escherichia coli O157:H7 in stools.

Authors:  A Mackenzie; E Orrbine; L Hyde; M Benoit; F Chan; C Park; J Alverson; A Lembke; D Hoban; W Kennedy
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

Review 5.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

6.  Human response to Escherichia coli O157:H7 infection: antibodies to secreted virulence factors.

Authors:  Y Li; E Frey; A M Mackenzie; B B Finlay
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

7.  Inactivation of Escherichia coli O157:H7 in simulated human gastric fluid.

Authors:  Mark L Tamplin
Journal:  Appl Environ Microbiol       Date:  2005-01       Impact factor: 4.792

8.  Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid.

Authors:  L L Cooling; K E Walker; T Gille; T A Koerner
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  Sensitivities and specificities of premier E. coli O157 and premier EHEC enzyme immunoassays for diagnosis of infection with verotxin (Shiga-like toxin)-producing Escherichia coli. The SYNSORB Pk Study investigators.

Authors:  A M Mackenzie; P Lebel; E Orrbine; P C Rowe; L Hyde; F Chan; W Johnson; P N McLaine
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

10.  An automated fluorescent PCR method for detection of shiga toxin-producing Escherichia coli in foods.

Authors:  S Chen; R Xu; A Yee; K Y Wu; C N Wang; S Read; S A De Grandis
Journal:  Appl Environ Microbiol       Date:  1998-11       Impact factor: 4.792
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.